THX Pharma Société Anonyme (EPA:ALTHX)
France · Delayed Price · Currency is EUR 3.160
-0.240 (-7.06%)
Oct 2, 2026, 5:35 PM CET
EPA:ALTHX Market Cap
EPA:ALTHX has a market cap or net worth of €43.6 million as of October 2, 2026. Its market cap has increased by 70.42% in one year.
Market Cap
43.60M
Enterprise Value
38.71M
Revenue
806.05K
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.16
ChartMarket Cap Chart
Since October 26, 2017, EPA:ALTHX's market cap has decreased from 49.97M to 43.60M, a decrease of -12.75%. That is a compound annual growth rate of -1.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 43.60M | 47.66% |
| Dec 31, 2025 | 29.52M | 558.36% |
| Dec 31, 2024 | 4.48M | -48.39% |
| Dec 29, 2023 | 8.69M | -7.12% |
| Dec 30, 2022 | 9.36M | -58.65% |
| Dec 31, 2021 | 22.62M | -67.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 92.40M |
| Sensorion | 80.75M |
| ABIONYX Pharma | 74.43M |
| OSE Immunotherapeutics | 52.97M |
| Adocia | 52.36M |
| Fermentalg | 42.17M |
| Nicox | 29.96M |
| GenSight Biologics | 26.68M |